Lexeo Therapeutics, Inc. Common Stock
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Lexeo Therapeutics, Inc. Common Stock generated cash of -$59,496,000, which is less than the previous year. Cash used in financing activities reached the amount of $103,791,000 last year. Net change in cash is therefore $44,130,000.
Cash Flow
| 2020 | -3.13M | 0 | 32.37M |
|---|---|---|---|
| 2021 | -44.18M | -188K | 150.85M |
| 2022 | -54.56M | -901K | 189K |
| 2023 | -59.49M | -165K | 103.79M |
LXEO Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 80.58M | 135.86M | 29.37M | 127.86K |
Operating activities | ||||
Net income | -66.39M | -59.27M | -50.62M | -5.15M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 1.84M | 1.14M | 13K | 0 |
Stock-based compensation expense | 3.04M | 1.78M | 386K | 0 |
| Deferred income tax benefit | 3.04M | 1.78M | 386K | 0 |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | -180K | -426K | 3.01M | 44.31K |
Cash generated by operating activities | -59.49M | -54.56M | -44.18M | -3.13M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -115K | -901K | -188K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -165K | -901K | -188K | 0 |
Financing activities | ||||
Common Stock Issued | 100.25M | 352K | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 3.57M | -163K | 0 | -2.60M |
Cash used in financing activities | 103.79M | 189K | 150.85M | 32.37M |
Net Change In Cash | 44.13M | -55.27M | 106.48M | 29.24M |
Cash at end of period | 124.71M | 80.58M | 135.86M | 29.37M |
| Data source |